# RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)

> **NCT07295132** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Asan Medical Center** · enrollment: 160 (estimated)

## Conditions studied

- Ovarian Cancer Recurrent
- Platinum Sensitive Ovarian Cancer

## Interventions

- **PROCEDURE:** Secondary cytoreductive surgery
- **DRUG:** Platinum Based Chemotherapy

## Key facts

- **NCT ID:** NCT07295132
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2029-11-15
- **Final completion:** 2029-11-15
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07295132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07295132, "RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07295132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*